The shameful decision of Pfizer’s chief executive officer, Albert Bourla, to cancel his participation in today’s debate organised by the European Parliament’s special committee on Covid-19 is completely unacceptable and cannot go unanswered, underline the S&Ds.
Today, the Parliament’s committee on Covid-19 will hold a debate with representatives of five pharmaceutical companies - Pfizer, CureVac, Novavax, Glaxo Smith Kline, and HIPRA. Pfizer is the only company who will not participate with their leading representative.